Zhiliang Jia

The University of Texas MD Anderson Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

36h-index3.8kcitations231works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

FOXO transcription factor regulation(78), Kruppel-like factors research(69), Cancer-related gene regulation(47), Epigenetics and DNA Methylation(39), Genetic Syndromes and Imprinting(39)

Publications231 total

Fgl2-knockout tumor cells serve as a vaccine inducing long-duration brain-resident memory T cells that reject subsequent intracranial tumor cell challenges
Cancer Letters·2025Open Access
Anti-CD137 agonist antibody-independent and clinically feasible preparation of tumor-infiltrating lymphocytes from soft tissue sarcoma and osteosarcoma 2023
The Journal of Immunology·2025Open Access
Anti-CD137 agonist antibody–independent and clinically feasible preparation of tumor-infiltrating lymphocytes from soft tissue sarcoma and osteosarcoma
Frontiers in Immunology·2025· 4 citedOpen Access
Supplementary Figures from Lamin B1 Is a Novel Therapeutic Target of Betulinic Acid in Pancreatic Cancer
2023Open Access
Supplementary Figure Legends from Lamin B1 Is a Novel Therapeutic Target of Betulinic Acid in Pancreatic Cancer
2023Open Access
Supplementary Materials and Methods from Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression through Activation of Hepatocyte Nuclear Factor-6
2023Open Access
Data from Lamin B1 Is a Novel Therapeutic Target of Betulinic Acid in Pancreatic Cancer
2023Open Access
Data from ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin
2023Open Access
Supplementary Tables 1 - 9 from The Critical Role of Dysregulated FOXM1–PLAUR Signaling in Human Colon Cancer Progression and Metastasis
2023Open Access
Supplementary Tables from STK33 Promotes Growth and Progression of Pancreatic Cancer as a Critical Downstream Mediator of HIF1α
2023Open Access
Supplemenetary Figures 1 through 4 from ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin
2023Open Access
Supplementary Figure S4 from Activation of Vitamin D Receptor Signaling Downregulates the Expression of Nuclear FOXM1 Protein and Suppresses Pancreatic Cancer Cell Stemness
2023Open Access
Supplementary Information from Methylation of HSP70 Orchestrates Its Binding to and Stabilization of BCL2 mRNA and Renders Pancreatic Cancer Cells Resistant to Therapeutics
2023Open Access
Supplementary Tables 1-2 from The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer
2023Open Access
Data from Krüppel-like Factor 4 Blocks Hepatocellular Carcinoma Dedifferentiation and Progression through Activation of Hepatocyte Nuclear Factor-6
2023Open Access
Supplementary Tables from Lamin B1 Is a Novel Therapeutic Target of Betulinic Acid in Pancreatic Cancer
2023Open Access
Data from Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling
2023Open Access
Supplementary Tables from STK33 Promotes Growth and Progression of Pancreatic Cancer as a Critical Downstream Mediator of HIF1α
2023Open Access
Supplementary Figures 1-8 from DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression
2023Open Access
Supplementary Figures 1 - 3 from The Critical Role of Dysregulated FOXM1–PLAUR Signaling in Human Colon Cancer Progression and Metastasis
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Keping Xie(40), Daoyan Wei(27), Xiangdong Le(16), Suyun Huang(15), Jiujie Cui(13), Dacheng Xie(11), Xiangyu Kong(10), Yong Gao(9), James C. Yao(6), Liwei Wang(6), Shulin Li(6), Qiang Li(5), Xueqing Xia(5), Huamei Tang(5), Lopa Mishra(5), Chen Huang(4), Zhiwei Li(4), Jiemiao Hu(4), Jun Zhang(4), Shaojiang Zheng(3)